Specific Therapy Based on the Genotype and Cellular Mechanism in Inherited Cardiac Arrhythmias. Long QT Syndrome and Brugada Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|12|1561-1572

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.12, 2005-01, pp. : 1561-1572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging targets in the long QT syndromes and Brugada syndrome

By Towbin J.A. Vatta M. Wang Z. Bowles N.E. Li H.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 423-437

Informa Healthcare

Access to resources Recommend Favorite

Genotype-Specific Risk Stratification and Management of Patients with Long QT Syndrome

By Barsheshet Alon Dotsenko Olena Goldenberg Ilan

Annals of Noninvasive Electrocardiology, Vol. 18, Iss. 6, 2013-11 ,pp. : 499-509

Blackwell Publishing

Access to resources Recommend Favorite

Medical Therapy for Long QT Syndrome

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 6, 2018-03 ,pp. : 495-506

Bentham Science Publishers

Access to resources Recommend Favorite

Congenital long QT syndromes and Brugada syndrome: the arrhythmogenic ion channel disorders

By Nemec J. Shen W-K.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 773-797

Informa Healthcare

Access to resources Recommend Favorite

Pilsicainide induces ventricular arrhythmias in patients with Brugada syndrome

Inpharma, Vol. 1, Iss. 1415, 2003-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite